IRTC250117C50000
- 41.85
- 0.000.00%
iRhythm Technologies Newsroom
Is It Too Late To Consider Buying IRhythm Technologies, Inc. (NASDAQ:IRTC)?
The Five-year Returns Have Been for IRhythm Technologies (NASDAQ:IRTC) Shareholders Despite Underlying Losses Increasing
Needham Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $125
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $100
Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $120
CCORF Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $152
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating
Irhythm Technologies (IRTC) Gets a Buy From Truist Financial
IRhythm Technologies Shares Fall 8% Following 2024, 2025 Outlooks
Express News | IRhythm Technologies Shares Are Trading Lower. The Company Reported Preliminary Q4 Financial Results
Needham Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $112
Irhythm Technologies: Positive Revenue Projections and Growth Prospects Reinforce Buy Rating
Express News | Needham Maintains Buy on IRhythm Technologies, Raises Price Target to $112
IRhythm Technologies Anticipates 2024 Revenue Above $587.5M; Expect Revenue For FY25 Of ~$675M-$685M
IRhythm Technologies Reports Strong Growth and Innovation
Express News | IRhythm Technologies: Anticipate 2024 Revenue Slightly Above High End of Previously Stated Guidance Range of $587.5 Mln
IRhythm Technologies Sees FY25 Rev $675M-$685M >IRTC
Press Release: IRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
IRhythm Technologies Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $120